Novo Nordisk's jabs like Ozempic helps type 1 diabetes patients lose weight: Study
People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently approved only for type 2 diabetes, according to results from a small trial.
Semaglutide is the active ingredient in Novo Nordisk's diabetes drugs Ozempic and Rybelsus, as well as its weight-loss treatment Wegovy.
In the first clinical trial testing the Novo drug in people with type 1 diabetes and obesity, the 36 patients who received weekly semaglutide injections along with their usual insulin spent more time in their target blood sugar range and lost more weight than 36 similar patients who got a placebo along with their insulin, study leader Dr. Viral Shah of Indiana University School of Medicine reported at the American Diabetes Association meeting in Chicago.
All of the patients were using automated insulin delivery systems and had a body mass index of 30 or higher, which is considered obese.
One-third of the patients in the semaglutide group achieved all three of the study's goals: blood sugar in the target range of 70 to 180 mg/dL more than 70 percent of the time, dangerously low blood sugar less than 4 percent of the time, and body weight reduction of at least 5 percent. The average weight loss with semaglutide was 20 pounds (9 kg).
No one in the placebo group achieved all three of these milestones, according to a report of the study published in NEJM Evidence.
'We hope that our trial will encourage the industry to conduct a regulatory approval trial so that this drug could be available as an adjunct to insulin therapy to optimize type 1 diabetes management,' Shah said in a statement.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Al Arabiya
a day ago
- Al Arabiya
J.M. Smucker plans to remove artificial colors from its jams and other products by the end of 2027
J.M. Smucker Co. plans to remove artificial colors from its products by the end of 2027. Orrville, Ohio–based Smucker said Thursday it will also remove synthetic dyes from foods sold to K–12 schools by the 2026–2027 school year. Smucker said the majority of its products – including its Uncrustables sandwiches – are already free of synthetic dyes. But some products still have them, including sugar-free jams and ice cream toppings. Smucker said some products from Hostess, which it acquired in 2023, also contain artificial colors. Twinkies are made with Red 40 and Yellow 5, for example, while Sno Balls snack cakes are made with Red 40 Lake, a dye combined with aluminum to keep it from dissolving in water. Smucker joins a growing number of big food companies that have announced plans to eliminate artificial dyes. Earlier this week, Nestle and Conagra Brands – the parent company of Duncan Hines – both said they would phase out synthetic dyes. Kraft Heinz and General Mills made similar pledges last week. The federal government has stepped up its scrutiny of artificial colors in recent months. In January, days before President Donald Trump took office, the US regulators banned the dye called Red 3 from the nation's food supply nearly 35 years after it was barred from cosmetics because of potential cancer risk. In April, Trump's Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary said the agency would take steps to eliminate synthetic dyes by the end of 2026, largely by relying on voluntary efforts from the food industry.


Al Arabiya
a day ago
- Al Arabiya
Residents express amazement after seeing mystery object streak across the sky
More than 200 people across a half-dozen southern US states have now reported witnessing a mysterious object streak across the sky on Thursday, but no one is certain exactly what it was. The object was likely either a meteor or space junk, with most sightings of the streak of light and fireball coming from Georgia and South Carolina around 12:30 p.m., according to a report from the National Weather Service office in Peachtree City, Georgia. People expressed amazement in witness accounts. As of Friday afternoon, at least 215 reports of the object have poured into the American Meteor Society, with many people expressing wonder and amazement in their reports. 'It was a bright fireball,' a woman in Bethlehem, Georgia, wrote. 'It did have a bright tail that disappeared with it and left behind a smoke trail,' she added. 'I've never seen anything like it before.' A man in Milledgeville, Georgia, reported, 'I believe it hit the ground.' The roof of a Georgia home is pierced. A resident of Henry County, Georgia, reported a rock coming through their roof around the time they heard the sonic boom from the fireball. It left behind a hole in the ceiling about the size of a golf ball and a crack in a laminate floor at the home southeast of Atlanta, according to the National Weather Service office in Peachtree City, Georgia. 'We are presuming that a piece of the object fell through their roof,' the weather service said in a brief statement on social media. Dashboard and doorbell cameras across several states in the southeastern US states caught glimpses of the fireball that appeared to be plummeting straight down. Broad daylight sighting is rare. Meteors and other space debris frequently enter Earth's atmosphere, but it is rare for an object to be so bright it can easily be seen in broad daylight. Videos of the event showed clear skies on Thursday, allowing many to see the object falling. 'First time to ever see an event in daylight like this,' a man in Cumming, Georgia, north of Atlanta, said in his report to the meteor society. 'It was so bright in the middle of the day… brighter than the sun,' a woman in Dublin, Georgia, reported. Bright fireballs are caused by friction as an object enters the atmosphere and slows down considerably. Almost all objects break into minuscule pieces before striking the ground, according to NASA.


Al Arabiya
a day ago
- Al Arabiya
A Rundown of Recent Trump Administration Vaccine Policy Changes
The Trump administration continued to reshape US health policy in recent days with several moves that could change what vaccines people can get to protect themselves from common illnesses. Some of the changes are immediate; others are still being discussed, and Health Secretary Robert F. Kennedy Jr. must still sign off on some. Doctors' groups have expressed alarm at the moves made by Kennedy, a longtime anti-vaccine activist, and his appointees, who at times have ignored well-established science. Nearly 80 medical groups, including the American Medical Association, issued a statement backing vaccines against common respiratory ailments as among the best tools to protect the public. 'We come together as physicians from every corner of medicine to reaffirm our commitment to these lifesaving vaccines,' the groups wrote. Here's what to know about some of the recent vaccine policy changes: Flu shots and thimerosal On Thursday, a vaccine advisory group handpicked by Kennedy recommended that just about every American get a flu shot this fall. But the group also said people should avoid shots containing thimerosal, a preservative used only in large multi-dose vials that has been proven to be safe. The ingredient isn't used in single-dose flu shots–the type of syringe used for about 95 percent of US flu shots last season. Status: Kennedy must sign off on the recommendations. How to get a COVID-19 shot Universal access to updated COVID-19 shots for the fall remains unclear, even after Kennedy's vaccine advisers were shown data showing how well the vaccines are working. Kennedy changed CDC guidance last month, saying the shots are no longer recommended for healthy children and pregnant women–even though doctors' groups disagree. And the Food and Drug Administration has moved to limit COVID-19 vaccinations among healthy people under age 65. Status: Upcoming advisory meetings, regulatory decisions, and policies from insurers and employers are likely to influence access. Expanded warnings on COVID-19 vaccine labels At the request of the FDA, makers of the two leading COVID-19 vaccines on Wednesday expanded existing warnings about a rare heart side effect mainly seen in young men. Prescribing information from both Pfizer and Moderna had already advised doctors about rare cases of myocarditis, a type of heart inflammation that is usually mild. The FDA had asked the drugmakers to add more detail about the problem and to cover a larger group of patients. Status: Labels are being updated now. Changes considered for the childhood vaccine schedule On Wednesday, Kennedy's vaccine advisers said they would be evaluating the cumulative effect of the children's vaccine schedule–the list of immunizations given at different times throughout childhood. The announcement reflected vaccine skeptics' messaging: that too many shots may overwhelm kids' immune systems. Scientists say those claims have been repeatedly investigated with no signs of concern. The American Academy of Pediatrics said it would continue publishing its own vaccine schedule for children but now will do so independently of the government advisory panel, calling it 'no longer a credible process.' Status: The examination is in its early stages.